WithdrawnPHASE1, PHASE2NCT00293436

Celecoxib and Erlotinib in Treating Patients With Liver Cancer

Studying Adult hepatocellular carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
Alan P. Venook, MD, M.D
University of California, San Francisco
Intervention
celecoxib(drug)
Eligibility
18 years · All sexes
Timeline
2005

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Published results

No published results indexed yet.Verified against PubMed's DataBankList cross-reference. This means either: (a) the trial has not yet published, (b) results were published without registering the NCT cross-reference, or (c) our index is still catching up. Patients can check ClinicalTrials.gov directly or search PubMed for the PI's recent work.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00293436 on ClinicalTrials.gov

Other trials for Adult hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Adult hepatocellular carcinoma →

← Back to all trials